Works matching IS 22107703 AND DT 2024 AND VI 46 AND IP 2
Results: 25
European Society of Clinical Pharmacy: 'Implementing and scaling sustainable clinical pharmacy'.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 355, doi. 10.1007/s11096-024-01718-w
- By:
- Publication type:
- Article
Correction: Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 522, doi. 10.1007/s11096-024-01701-5
- By:
- Publication type:
- Article
Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 548, doi. 10.1007/s11096-023-01695-6
- By:
- Publication type:
- Article
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 488, doi. 10.1007/s11096-023-01694-7
- By:
- Publication type:
- Article
First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 515, doi. 10.1007/s11096-023-01693-8
- By:
- Publication type:
- Article
Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trial.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 463, doi. 10.1007/s11096-023-01692-9
- By:
- Publication type:
- Article
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 542, doi. 10.1007/s11096-023-01689-4
- By:
- Publication type:
- Article
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 536, doi. 10.1007/s11096-023-01687-6
- By:
- Publication type:
- Article
Pharmacists working in residential aged care: a survey of pharmacist interest and perceived preparedness.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 506, doi. 10.1007/s11096-023-01686-7
- By:
- Publication type:
- Article
Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 496, doi. 10.1007/s11096-023-01683-w
- By:
- Publication type:
- Article
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 451, doi. 10.1007/s11096-023-01681-y
- By:
- Publication type:
- Article
Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 480, doi. 10.1007/s11096-023-01678-7
- By:
- Publication type:
- Article
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 401, doi. 10.1007/s11096-023-01669-8
- By:
- Publication type:
- Article
Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 471, doi. 10.1007/s11096-023-01676-9
- By:
- Publication type:
- Article
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 429, doi. 10.1007/s11096-023-01675-w
- By:
- Publication type:
- Article
Screening for atrial fibrillation in care homes using pulse palpation and the AliveCor Kardia Mobile® device: a comparative cross-sectional pilot study.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 529, doi. 10.1007/s11096-023-01672-z
- By:
- Publication type:
- Article
The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 368, doi. 10.1007/s11096-023-01671-0
- By:
- Publication type:
- Article
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 411, doi. 10.1007/s11096-023-01677-8
- By:
- Publication type:
- Article
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 421, doi. 10.1007/s11096-023-01668-9
- By:
- Publication type:
- Article
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 382, doi. 10.1007/s11096-023-01667-w
- By:
- Publication type:
- Article
The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 357, doi. 10.1007/s11096-023-01666-x
- By:
- Publication type:
- Article
Communication skills-based training about medication switch encounters: pharmacy staff and patients' experiences.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 439, doi. 10.1007/s11096-023-01664-z
- By:
- Publication type:
- Article
Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation: Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION)
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 390, doi. 10.1007/s11096-023-01640-7
- By:
- Publication type:
- Article